Antonini, Angelo http://orcid.org/0000-0003-1040-2807
Pahwa, Rajesh http://orcid.org/0000-0003-3176-6466
Odin, Per http://orcid.org/0000-0002-0756-7478
Isaacson, Stuart H. http://orcid.org/0000-0002-9914-5706
Merola, Aristide http://orcid.org/0000-0002-5587-726X
Wang, Lin
Kandukuri, Prasanna L.
Alobaidi, Ali http://orcid.org/0000-0002-0720-7894
Yan, Connie H. http://orcid.org/0000-0003-1467-4666
Bao, Yanjun
Zadikoff, Cindy
Parra, Juan Carlos http://orcid.org/0000-0002-5613-6121
Bergmann, Lars
Chaudhuri, K. Ray http://orcid.org/0000-0003-2815-0505
Funding for this research was provided by:
AbbVie
Article History
Accepted: 29 September 2022
First Online: 21 November 2022
Declarations
:
: This study and its open access publication was supported and funded by AbbVie Inc. AbbVie participated in study design, research, data collection, analysis and interpretation of data, writing, reviewing, and approving the publication.
: Angelo Antonini has received compensation for consultancy and speaker-related activities from UCB, Boehringer Ingelheim, Britannia, AbbVie, Kyowa Kirin, Zambon, Bial, Neuroderm, Theravance Biopharma, Roche. He receives research support from Chiesi Pharmaceuticals, Lundbeck, Bial, Horizon2020 Grant 825785, Horizon2020 Grant 101016902, Ministry of Education University and Research (MIUR) Grant ARS01_01081, Cariparo Foundation. He serves as consultant for Boehringer–Ingelheim for legal cases on pathological gambling. Rajesh Pahwa has received consulting fees from AbbVie, ACADIA, Acorda, Adamas, Cynapsus, Global Kinetics, Lundbeck, Neurocrine, Pfizer, Sage, Sunovion, Teva Neuroscience and US World Meds. He has received research grants from AbbVie, Adamas, Avid, Biotie, Boston Scientific, Civitas, Cynapsus, Kyowa, National Parkinson Foundation, NIH/NINDS, Parkinson Study Group. Per Odin has received compensations for consultancy and speaker-related activities from AbbVie, Bial, Britannia, Ever Pharma, Lobsor, Nordic Infucare, Stada, and Zambon. He has received royalties from Uni-Med Verlag. Stuart Isaacson has received honoraria for CME, consultant, research grants, and/or promotional speaker on behalf of AbbVie, Acadia, Acorda, Adamas, Addex, Affiris, Alexva, Allergan, Amarantus, Amneal, Aptinyx, Axial, Axovant, Benevolent, Biogen, Britannia, Cadent, Cala, Cerecor, Cerevel, Cipla, Eli Lilly, Enterin, GE Healthcare, Global Kinetics, Impax, Impel, Intec Pharma, Ipsen, Jazz, Kyowa, Lundbeck, Merz, Michael J. Fox Foundation, Mitsubishi Tanabe, Neuralys, Neurocrine, Neuroderm, Parkinson Study Group, Pharma2B, Prilenia, Promentis, Revance, Roche, Sanofi, Sunovion, Sun Pharma, Supernus, Teva, Theravance, UCB. Aristide Merola has received grant support from the NIH (KL2 TR001426). He has received speaker honoraria or advisory board honoraria from CSL Behring, AbbVie, Abbott, Medtronic, Theravance, and Cynapsus Therapeutics. He has received grant support from Lundbeck and AbbVie. Lin Wang, Lakshmi P. Kandukuri, Ali Alobaidi, Yanjun Bao, Cindy Zadikoff, Juan Carlos Parra, Lars Bergmann, and Connie H. Yan are employees of AbbVie and may own stocks/shares in the company. K. Ray Chaudhuri has received educational funding from UCB, and honoraria for sponsored symposia from UCB, AbbVie, Britannia, US Worldmeds, Otsuka, Medtronic, Zambon and acted as a consultant for AbbVie, UCB, Britannia, Medtronic, and Mundipharma.
: As this is a retrospective study with anonymous data, no Ethics Committee or Institutional Review Board approvals were needed.
: As this is a retrospective study with anonymous data, no patient consent was needed.
: Not applicable.
: Not applicable.
: All data included in this analysis are in the public domain in the individual published studies.
: All authors meet the ICMJE criteria for authorship, and have contributed to the development of the manuscript, and read and approved the final version for submission and agree to be accountable for the work. The concept of the article was provided by Angelo Antonini, Yash J. Jalundhwala and Lin Wang. Lin Wang and Prasanna L. Kandukuri provided the data analysis.